English | Español
Kerry Goff | Dec 1, 2015

University of Toronto's new ALS research may have pinpointed cause of disease
Jamie Barrand | Nov 28, 2015

AMA discussion seeks to improve veterans affairs, stop opioid abuse
Jamie Barrand | Nov 27, 2015

FDA conducts sweep of dietary supplement companies
Jamie Barrand | Nov 26, 2015

Intravenous form of ibuprofen now available in Australia
Jamie Barrand | Nov 26, 2015

American Cancer Society officials call for Congress to take action on tobacco issues
Jamie Barrand | Nov 25, 2015

CDC develops new resources for epilepsy patients, health care providers
Jamie Barrand | Nov 25, 2015

CRS-207 designated as orphan drug for mesothelioma treatment
Jamie Barrand | Nov 25, 2015

Opdivo becomes sole PD-1 inhibitor to increase survival rate of renal cell carcinoma patients

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'